Prescription Costs A Burden For Two-Thirds Of Americans, Survey Finds

Two-thirds of Americans who filled a prescription in 2024 described the cost of their medication as a burden, a new survey from GoodRx found.

“For millions of Americans, affording prescription medications is getting harder, not easier,” according to the survey report. “People are more likely than ever to view their prescriptions as a financial burden. More people are skipping doses, cutting back on essentials or turning to creative — and sometimes risky — workarounds to continue their prescribed treatment.”

Survey respondents described their out-of-pocket expenses for medication as a minor burden (35%); moderate burden (21%); significant burden (10%); catastrophic burden (2%); or not a burden (33%).

Prescription drugs are one of many competing expenses for most Americans. For many, medication costs now rank higher than concerns about housing, food and transportation.

In 2025, nearly 4 in 10 people said they worried about being able to afford their medications, up significantly from 27% in 2024. More than half worried about affording at least one health care or essential cost in the past year.

As a result, 37% of Americans reported taking action last year that could negatively affect their lifestyle or personal finances – and the pinch is getting worse. In 2025, that number went up to 46%, with lifestyle sacrifices common:

  • Three in 10 cut spending on leisure activities (up from 23% in 2024).
  • Twenty-eight percent reduced spending on food or clothing (a sharp increase from 16% in 2024).
  • Sixteen percent dipped into savings to cover the cost of treatment.
  • Nine percent sold personal belongings to help pay for medications.
  • Fifteen percent adjusted their or a family member’s employment, either by working more hours or taking on an additional job.

In addition to lifestyle changes, many consumers took on direct financial burdens to cover health care costs. One quarter added credit card debt; 18% borrowed money from friends or family; and 6% took out a loan. The cost squeeze may be affecting consumers’ health as well as their pocketbook. In 2024, 34% of respondents reported making at least one change to how they managed their prescriptions because of cost. By 2025, that number went up to 42%. This includes 16% who delayed refills; 20% who rationed their medications; and 13% who stopped taking a medication entirely.

“Prescription medications remain a financial burden for most Americans,” the report concluded. “Almost 1 in 12 Americans has medical debt, with the cost of prescription medications contributing to the problem. In the face of unaffordable medications, many Americans are taking their health care into their own hands. They are seeking out discount programs, using manufacturer copay cards and talking to their health care professional about the cost of care. Expanding these resources is an important first step to improving medication access and affordability.”

 

 

Source Link

Recommended Articles

CMS Finalizes Major Changes To ACA Exchanges, Including Greater Access To Catastrophic Plans

Editor’s Note: Covered California is a State-Based Marketplace (SBM). For details on how these new rules will impact Covered California and other SBMs we recommend the following Princeton University linked report: (Broker rule changes appear at the bottom of the Princeton analysis.) https://shvs.org/wp-content/uploads/2025/06/SHVS_2025-Final-Marketplace-Integrity-Rule.pdf.   The Trump administration on Friday finalized a major rule reshaping the ...

Read More

Eroding ACA Enrollment Portends Higher Insurance Rates

Enrollment in the Affordable Care Act continues to erode as some customers struggle to make premium payments, with the declining numbers churning market uncertainty for insurers. In response, insurers are likely to raise rates again next year, following this year’s larger-than-typical hikes. Sign-ups were already down in January by about 1.2 million from last year’s record enrollment. For ...

Read More

White House Adds Generic Drugs To Direct-To-Consumer TrumpRx Site

The Trump administration on Monday said it is adding generic medications to its direct-to-consumer drug sales website, TrumpRx, in a bid to expand a platform that is key to his administration’s efforts to lower prescription drug costs in the U.S. The administration is adding more than 600 generic drugs to the site, President Donald Trump said at an event ...

Read More

Supreme Court Rejects Big Pharma Appeals Challenging Negotiated Drug Prices In Medicare

The US Supreme Court on Monday rejected a series of appeals from several of the nation’s largest drugmakers challenging a program that is expected to save taxpayers and the federal government billions of dollars by requiring the companies to negotiate with Medicare on the prices for some of their most popular drugs. The court’s decision to deny ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square